XML 54 R43.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Summary of Components of Current and Deferred Portions of Provision for Income Taxes

The components of our current and deferred portions of the provision for income taxes are presented in the table below:

 

 

 

Years Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Current income tax (provision) benefit:

 

 

 

 

 

 

 

 

 

Federal

 

$

(40

)

 

$

(237

)

 

$

 

State

 

 

(115

)

 

 

(167

)

 

 

(22

)

Foreign

 

 

(2,847

)

 

 

(3,614

)

 

 

(3,256

)

Total Current

 

$

(3,002

)

 

$

(4,018

)

 

$

(3,278

)

Deferred income tax (provision) benefit:

 

 

 

 

 

 

 

 

 

Federal

 

$

 

 

$

 

 

$

 

State

 

 

 

 

 

 

 

 

 

Foreign

 

 

251

 

 

 

158

 

 

 

3,214

 

Total Deferred

 

$

251

 

 

$

158

 

 

$

3,214

 

Total provision for income taxes

 

$

(2,751

)

 

$

(3,860

)

 

$

(64

)

Summary of Reconciliation of Federal Statutory Rate and Provision for Income Taxes

The following reconciles the differences between income taxes computed at the federal statutory rate and the provision for income taxes:

 

 

 

Years Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Federal statutory income tax rate

 

 

21.0

%

 

 

21.0

%

 

 

21.0

%

State taxes, net of federal benefit

 

 

0.0

 

 

 

1.1

 

 

 

3.7

 

Valuation allowance

 

 

(20.4

)

 

 

(7.1

)

 

 

(18.5

)

Stock-based compensation

 

 

(2.3

)

 

 

(1.3

)

 

 

(5.1

)

Permanent differences

 

 

(2.0

)

 

 

(14.0

)

 

 

(0.7

)

Research and development credit

 

 

5.3

 

 

 

0.0

 

 

 

0.0

 

Other

 

 

(2.9

)

 

 

(0.3

)

 

 

(0.4

)

Effective income tax rate

 

 

(1.3

)%

 

 

(0.6

)%

 

 

%

Summary of Significant Components of Deferred Tax Assets and Liabilities Significant components of the Company's deferred tax assets and liabilities were as follows:

 

 

 

As of December 31,

 

 

 

2024

 

 

2023

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

258,002

 

 

$

229,264

 

Research and development credit carryforwards

 

 

15,234

 

 

 

1,660

 

Deferred revenue

 

 

298

 

 

 

2,687

 

Deferred compensation

 

 

7,571

 

 

 

5,687

 

Leasing obligation

 

 

2,138

 

 

 

3,087

 

Capitalized research expense

 

 

45,670

 

 

 

43,476

 

Other

 

 

3,736

 

 

 

2,415

 

Total deferred tax assets

 

 

332,648

 

 

 

288,276

 

Total valuation allowance

 

 

313,147

 

 

 

263,001

 

Total net deferred tax assets

 

 

19,501

 

 

 

25,275

 

Joint venture investment basis difference

 

 

(841

)

 

 

(1,054

)

Intangibles

 

 

(15,800

)

 

 

(20,879

)

Right-of-use assets

 

 

(1,878

)

 

 

(2,738

)

Other

 

 

(2,006

)

 

 

(1,902

)

Total deferred tax assets (liabilities)

 

 

(20,525

)

 

 

(26,573

)

Net deferred tax liabilities

 

$

(1,024

)

 

$

(1,298

)

 

Summary of Changes in Valuation Allowance for Deferred Tax Assets

Changes in the valuation allowance for deferred tax assets during the years ended December 31, 2024, 2023 and 2022 related primarily to the increase in net operating loss carryforwards in 2024, 2023 and 2022 and were as follows:

 

 

 

Years Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Valuation allowance as of beginning of the year

 

$

263,001

 

 

$

214,776

 

 

$

164,391

 

Increases recorded to income tax provision

 

 

50,146

 

 

 

48,225

 

 

 

50,403

 

Decreases recorded as a benefit to income tax provision

 

 

 

 

 

 

 

 

(18

)

Valuation allowance as of end of year

 

$

313,147

 

 

$

263,001

 

 

$

214,776